Lee Ainslie Novartis Ag Put Options Transaction History
Maverick Capital LTD
- $5.07 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,436Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.32 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$804 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$803 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$644 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $233B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...